Skip to main content
Top
Published in: BMC Nephrology 1/2024

Open Access 01-12-2024 | Chronic Kidney Disease | Research

Trajectories of atherosclerotic cardiovascular disease risk scores as a predictor for incident chronic kidney disease

Authors: Hye Sun Lee, Hong Il Lim, Tae Ju Moon, So Young Lee, Jun-Hyuk Lee

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

The relationship between atherosclerosis and renal function is well established. Atherosclerotic cardiovascular disease (ASCVD) risk scores reflect atherosclerotic burden, which changes over time. We investigated the association between ASCVD risk trajectories and incident chronic kidney disease (CKD) using data from a large community-based Korean cohort with up to 16 years of follow-up.

Methods

We analyzed data from 5032 participants without CKD from the baseline survey of the Korean Genome and Epidemiology Study Ansan-Ansung cohort. Participants were categorized into stable or increasing ASCVD risk groups based on the revised ASCVD risk pooled cohort equation over a median period of exposure of 5.8 years. Incident CKD was defined as two consecutive events of an estimated glomerular filtration rate < 60 mL/min/1.73 m2.

Results

During a median 9.9 years of event accrual period, 449 (8.92%) new-onset CKD cases were identified. Multiple Cox proportional regression analyses showed that the hazard ratio (95% confidence interval) for incident CKD in the increasing group, compared to the stable group, was 2.13 (1.74–2.62) in the unadjusted model and 1.35 (1.02–1.78) in the fully-adjusted model. Significant relationships were maintained in subgroups of individuals in their 50s, without diabetes mellitus or hypertension. The prevalence of proteinuria was consistently higher in the increasing group than that in the stable group.

Conclusions

An increasing trend in ASCVD risk scores independently predicted adverse renal outcomes in patients without diabetes mellitus or hypertension. Continuous monitoring of ASCVD risk is not only important for predicting cardiovascular disease but also for predicting CKD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vasan RS, Pan S, Larson MG, Mitchell GF, Xanthakis V. Arteriosclerosis, atherosclerosis, and cardiovascular health: joint relations to the incidence of cardiovascular disease. Hypertension. 2021;78(5):1232–40.CrossRefPubMed Vasan RS, Pan S, Larson MG, Mitchell GF, Xanthakis V. Arteriosclerosis, atherosclerosis, and cardiovascular health: joint relations to the incidence of cardiovascular disease. Hypertension. 2021;78(5):1232–40.CrossRefPubMed
3.
go back to reference Muntner P, Colantonio LD, Cushman M, Goff DC Jr, Howard G, Howard VJ, Kissela B, Levitan EB, Lloyd-Jones DM, Safford MM. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations. JAMA. 2014;311(14):1406–15.CrossRefPubMedPubMedCentral Muntner P, Colantonio LD, Cushman M, Goff DC Jr, Howard G, Howard VJ, Kissela B, Levitan EB, Lloyd-Jones DM, Safford MM. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations. JAMA. 2014;311(14):1406–15.CrossRefPubMedPubMedCentral
4.
go back to reference Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.CrossRefPubMed Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.CrossRefPubMed
5.
6.
go back to reference Wojtaszek E, Oldakowska-Jedynak U, Kwiatkowska M, Glogowski T, Malyszko J. Uremic toxins, oxidative stress, atherosclerosis in chronic kidney disease, and kidney transplantation. Oxid Med Cell Longev. 2021;2021:6651367.CrossRefPubMedPubMedCentral Wojtaszek E, Oldakowska-Jedynak U, Kwiatkowska M, Glogowski T, Malyszko J. Uremic toxins, oxidative stress, atherosclerosis in chronic kidney disease, and kidney transplantation. Oxid Med Cell Longev. 2021;2021:6651367.CrossRefPubMedPubMedCentral
7.
go back to reference Valdivielso JM, Rodríguez-Puyol D, Pascual J, Barrios C, Bermúdez-López M, Sánchez-Niño MD, Pérez-Fernández M, Ortiz A. Atherosclerosis in chronic kidney disease: more, less, or just different? Arterioscler Thromb Vasc Biol. 2019;39(10):1938–66.CrossRefPubMed Valdivielso JM, Rodríguez-Puyol D, Pascual J, Barrios C, Bermúdez-López M, Sánchez-Niño MD, Pérez-Fernández M, Ortiz A. Atherosclerosis in chronic kidney disease: more, less, or just different? Arterioscler Thromb Vasc Biol. 2019;39(10):1938–66.CrossRefPubMed
8.
go back to reference Ren H, Zhao L, Zou Y, Wang Y, Zhang J, Wu Y, Zhang R, Wang T, Wang J, Zhu Y, et al. Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus. Ren Fail. 2021;43(1):477–87.CrossRefPubMedPubMedCentral Ren H, Zhao L, Zou Y, Wang Y, Zhang J, Wu Y, Zhang R, Wang T, Wang J, Zhu Y, et al. Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus. Ren Fail. 2021;43(1):477–87.CrossRefPubMedPubMedCentral
9.
go back to reference Lu J, Mu Y, Su Q, Shi L, Liu C, Zhao J, Chen L, Li Q, Yang T, Yan L, et al. Reduced kidney function is associated with cardiometabolic risk factors, prevalent and predicted risk of cardiovascular disease in Chinese adults: results from the REACTION Study. J Am Heart Assoc. 2016;5(7):e003328.CrossRefPubMedPubMedCentral Lu J, Mu Y, Su Q, Shi L, Liu C, Zhao J, Chen L, Li Q, Yang T, Yan L, et al. Reduced kidney function is associated with cardiometabolic risk factors, prevalent and predicted risk of cardiovascular disease in Chinese adults: results from the REACTION Study. J Am Heart Assoc. 2016;5(7):e003328.CrossRefPubMedPubMedCentral
10.
go back to reference Chen F, Liu J, Han S, Xu T. Association between 10-year atherosclerotic cardiovascular disease risk and estimated glomerular filtration rate in Chinese people with normal to slightly reduced kidney function: a cross-sectional study. Int J Environ Res Public Health. 2022;19(23):16300.CrossRefPubMedPubMedCentral Chen F, Liu J, Han S, Xu T. Association between 10-year atherosclerotic cardiovascular disease risk and estimated glomerular filtration rate in Chinese people with normal to slightly reduced kidney function: a cross-sectional study. Int J Environ Res Public Health. 2022;19(23):16300.CrossRefPubMedPubMedCentral
11.
go back to reference Zhang Y, Yu Y, Zhu J, Zhao Q, Qiu Y, Cui S, Xiang Y, Wu Y, Ng N, Wang W, et al. Association between estimated glomerular filtration rate and 10-year atherosclerotic cardiovascular disease risk among community residents in Shanghai. China Nutr Metab Cardiovasc Dis. 2022;32(4):948–56.CrossRefPubMed Zhang Y, Yu Y, Zhu J, Zhao Q, Qiu Y, Cui S, Xiang Y, Wu Y, Ng N, Wang W, et al. Association between estimated glomerular filtration rate and 10-year atherosclerotic cardiovascular disease risk among community residents in Shanghai. China Nutr Metab Cardiovasc Dis. 2022;32(4):948–56.CrossRefPubMed
12.
go back to reference Kim Y, Han BG. Cohort Profile: The Korean Genome and Epidemiology Study (KoGES) Consortium. Int J Epidemiol. 2017;46(2):e20.CrossRefPubMed Kim Y, Han BG. Cohort Profile: The Korean Genome and Epidemiology Study (KoGES) Consortium. Int J Epidemiol. 2017;46(2):e20.CrossRefPubMed
13.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRefPubMedPubMedCentral
14.
go back to reference Diagnosis and Classification of Diabetes. Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20–s42. Diagnosis and Classification of Diabetes. Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20–s42.
15.
go back to reference Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, et al. 2020 international society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–57.CrossRefPubMed Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, et al. 2020 international society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–57.CrossRefPubMed
16.
go back to reference Yadlowsky S, Hayward RA, Sussman JB, McClelland RL, Min YI, Basu S. Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk. Ann Intern Med. 2018;169(1):20–9.CrossRefPubMed Yadlowsky S, Hayward RA, Sussman JB, McClelland RL, Min YI, Basu S. Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk. Ann Intern Med. 2018;169(1):20–9.CrossRefPubMed
17.
go back to reference Sinha P, Calfee CS, Delucchi KL. practitioner’s guide to latent class analysis: methodological considerations and common pitfalls. Crit Care Med. 2021;49(1):e63–79.CrossRefPubMedPubMedCentral Sinha P, Calfee CS, Delucchi KL. practitioner’s guide to latent class analysis: methodological considerations and common pitfalls. Crit Care Med. 2021;49(1):e63–79.CrossRefPubMedPubMedCentral
18.
go back to reference Proust-Lima C, Philipps V, Liquet B. Estimation of extended mixed models using latent classes and latent processes: the R package lcmm. J Stat Softw. 2017;78(2):1–56.CrossRef Proust-Lima C, Philipps V, Liquet B. Estimation of extended mixed models using latent classes and latent processes: the R package lcmm. J Stat Softw. 2017;78(2):1–56.CrossRef
19.
go back to reference Ohn JH, Kwak SH, Cho YM, Lim S, Jang HC, Park KS, Cho NH. 10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study. Lancet Diabetes Endocrinol. 2016;4(1):27–34.CrossRefPubMed Ohn JH, Kwak SH, Cho YM, Lim S, Jang HC, Park KS, Cho NH. 10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study. Lancet Diabetes Endocrinol. 2016;4(1):27–34.CrossRefPubMed
20.
go back to reference Lai D, Xu H, Koller D, Foroud T, Gao S. A multivariate finite mixture latent trajectory model with application to dementia studies. J Appl Stat. 2016;43(14):2503–23.CrossRefPubMed Lai D, Xu H, Koller D, Foroud T, Gao S. A multivariate finite mixture latent trajectory model with application to dementia studies. J Appl Stat. 2016;43(14):2503–23.CrossRefPubMed
21.
go back to reference Joo YS, Lee C, Kim HW, Jhee J, Yun HR, Park JT, Chang TI, Yoo TH, Kang SW, Han SH. Association of longitudinal trajectories of systolic BP with risk of incident CKD: results from the Korean Genome and Epidemiology Study. J Am Soc Nephrol. 2020;31(9):2133–44.CrossRefPubMedPubMedCentral Joo YS, Lee C, Kim HW, Jhee J, Yun HR, Park JT, Chang TI, Yoo TH, Kang SW, Han SH. Association of longitudinal trajectories of systolic BP with risk of incident CKD: results from the Korean Genome and Epidemiology Study. J Am Soc Nephrol. 2020;31(9):2133–44.CrossRefPubMedPubMedCentral
22.
go back to reference Park YC, Lee S, Kim YS, Park JM, Han K, Lee H, Hong KW, Kim JK, Cho ES, Chung TH, et al. Serum leptin level and incidence of CKD: a longitudinal study of adult enrolled in the Korean genome and epidemiology study(KoGES). BMC Nephrol. 2022;23(1):197.CrossRefPubMedPubMedCentral Park YC, Lee S, Kim YS, Park JM, Han K, Lee H, Hong KW, Kim JK, Cho ES, Chung TH, et al. Serum leptin level and incidence of CKD: a longitudinal study of adult enrolled in the Korean genome and epidemiology study(KoGES). BMC Nephrol. 2022;23(1):197.CrossRefPubMedPubMedCentral
23.
go back to reference Bundy JD, Rahman M, Matsushita K, Jaeger BC, Cohen JB, Chen J, Deo R, Dobre MA, Feldman HI, Flack J, et al. Risk prediction models for atherosclerotic cardiovascular disease in patients with chronic kidney disease: the CRIC study. J Am Soc Nephrol. 2022;33(3):601–11.CrossRefPubMedPubMedCentral Bundy JD, Rahman M, Matsushita K, Jaeger BC, Cohen JB, Chen J, Deo R, Dobre MA, Feldman HI, Flack J, et al. Risk prediction models for atherosclerotic cardiovascular disease in patients with chronic kidney disease: the CRIC study. J Am Soc Nephrol. 2022;33(3):601–11.CrossRefPubMedPubMedCentral
24.
go back to reference Li X, Lindholm B. Cardiovascular risk prediction in chronic kidney disease. Am J Nephrol. 2022;53(10):730–9.CrossRefPubMed Li X, Lindholm B. Cardiovascular risk prediction in chronic kidney disease. Am J Nephrol. 2022;53(10):730–9.CrossRefPubMed
25.
go back to reference Streja E, Norris KC, Budoff MJ, Hashemi L, Akbilgic O, Kalantar-Zadeh K. The quest for cardiovascular disease risk prediction models in patients with nondialysis chronic kidney disease. Curr Opin Nephrol Hypertens. 2021;30(1):38–46.CrossRefPubMed Streja E, Norris KC, Budoff MJ, Hashemi L, Akbilgic O, Kalantar-Zadeh K. The quest for cardiovascular disease risk prediction models in patients with nondialysis chronic kidney disease. Curr Opin Nephrol Hypertens. 2021;30(1):38–46.CrossRefPubMed
26.
go back to reference Rodgers JL, Jones J, Bolleddu SI, Vanthenapalli S, Rodgers LE, Shah K, Karia K, Panguluri SK. Cardiovascular risks associated with gender and aging. J Cardiovasc Dev Dis. 2019;6(2):19.PubMedPubMedCentral Rodgers JL, Jones J, Bolleddu SI, Vanthenapalli S, Rodgers LE, Shah K, Karia K, Panguluri SK. Cardiovascular risks associated with gender and aging. J Cardiovasc Dev Dis. 2019;6(2):19.PubMedPubMedCentral
27.
go back to reference Lind L, Sundström J, Ärnlöv J, Lampa E. Impact of aging on the strength of cardiovascular risk factors: a longitudinal study over 40 years. J Am Heart Assoc. 2018;7(1):e007061.CrossRefPubMedPubMedCentral Lind L, Sundström J, Ärnlöv J, Lampa E. Impact of aging on the strength of cardiovascular risk factors: a longitudinal study over 40 years. J Am Heart Assoc. 2018;7(1):e007061.CrossRefPubMedPubMedCentral
28.
go back to reference Liu P, Quinn RR, Lam NN, Al-Wahsh H, Sood MM, Tangri N, Tonelli M, Ravani P. Progression and regression of chronic kidney disease by age among adults in a population-based cohort in Alberta, Canada. JAMA Netw Open. 2021;4(6):e2112828.CrossRefPubMedPubMedCentral Liu P, Quinn RR, Lam NN, Al-Wahsh H, Sood MM, Tangri N, Tonelli M, Ravani P. Progression and regression of chronic kidney disease by age among adults in a population-based cohort in Alberta, Canada. JAMA Netw Open. 2021;4(6):e2112828.CrossRefPubMedPubMedCentral
29.
go back to reference Gembillo G, Ingrasciotta Y, Crisafulli S, Luxi N, Siligato R, Santoro D, Trifirò G. Kidney disease in diabetic patients: from pathophysiology to pharmacological aspects with a focus on therapeutic inertia. Int J Mol Sci. 2021;22(9):4824.CrossRefPubMedPubMedCentral Gembillo G, Ingrasciotta Y, Crisafulli S, Luxi N, Siligato R, Santoro D, Trifirò G. Kidney disease in diabetic patients: from pathophysiology to pharmacological aspects with a focus on therapeutic inertia. Int J Mol Sci. 2021;22(9):4824.CrossRefPubMedPubMedCentral
30.
go back to reference Fujii M, Ohno Y, Ikeda A, Godai K, Li Y, Nakamura Y, Yabe D, Tsushita K, Kashihara N, Kamide K, et al. Current status of the rapid decline in renal function due to diabetes mellitus and its associated factors: analysis using the National Database of Health Checkups in Japan. Hypertens Res. 2023;46(5):1075–89.CrossRefPubMedPubMedCentral Fujii M, Ohno Y, Ikeda A, Godai K, Li Y, Nakamura Y, Yabe D, Tsushita K, Kashihara N, Kamide K, et al. Current status of the rapid decline in renal function due to diabetes mellitus and its associated factors: analysis using the National Database of Health Checkups in Japan. Hypertens Res. 2023;46(5):1075–89.CrossRefPubMedPubMedCentral
31.
go back to reference Hanratty R, Chonchol M, Havranek EP, Powers JD, Dickinson LM, Ho PM, Magid DJ, Steiner JF. Relationship between blood pressure and incident chronic kidney disease in hypertensive patients. Clin J Am Soc Nephrol. 2011;6(11):2605–11.CrossRefPubMedPubMedCentral Hanratty R, Chonchol M, Havranek EP, Powers JD, Dickinson LM, Ho PM, Magid DJ, Steiner JF. Relationship between blood pressure and incident chronic kidney disease in hypertensive patients. Clin J Am Soc Nephrol. 2011;6(11):2605–11.CrossRefPubMedPubMedCentral
32.
go back to reference Said S, Hernandez GT. The link between chronic kidney disease and cardiovascular disease. J Nephropathol. 2014;3(3):99–104.PubMedPubMedCentral Said S, Hernandez GT. The link between chronic kidney disease and cardiovascular disease. J Nephropathol. 2014;3(3):99–104.PubMedPubMedCentral
33.
go back to reference Carracedo J, Alique M, Vida C, Bodega G, Ceprián N, Morales E, Praga M, de Sequera P, Ramírez R. Mechanisms of cardiovascular disorders in patients with chronic kidney disease: a process related to accelerated senescence. Front Cell Dev Biol. 2020;8:185.CrossRefPubMedPubMedCentral Carracedo J, Alique M, Vida C, Bodega G, Ceprián N, Morales E, Praga M, de Sequera P, Ramírez R. Mechanisms of cardiovascular disorders in patients with chronic kidney disease: a process related to accelerated senescence. Front Cell Dev Biol. 2020;8:185.CrossRefPubMedPubMedCentral
34.
go back to reference Satoh M. Endothelial dysfunction as an underlying pathophysiological condition of chronic kidney disease. Clin Exp Nephrol. 2012;16(4):518–21.CrossRefPubMed Satoh M. Endothelial dysfunction as an underlying pathophysiological condition of chronic kidney disease. Clin Exp Nephrol. 2012;16(4):518–21.CrossRefPubMed
Metadata
Title
Trajectories of atherosclerotic cardiovascular disease risk scores as a predictor for incident chronic kidney disease
Authors
Hye Sun Lee
Hong Il Lim
Tae Ju Moon
So Young Lee
Jun-Hyuk Lee
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03583-1

Other articles of this Issue 1/2024

BMC Nephrology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.